TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Clinical Neurological Sciences: 2000-2001

BLUME, W.T.

Blume, W.T. 2001. Current trends in electroencephalography. Current Opinion in Neurology 14 (2): 193-197.

Blume, W.T. 2000. Effect of temporal lobe resection on seizure semiology. Epileptic Seizures: Pathophygiolosy and Clinical Semiology. H.O. Luders, and S. Noachtar. Philadelphia.: Churchhill Livingstone Inc. 547-556.

Blume, W.T. 2001. Electroencephalography and Epilepsy. Epilepsy: Comprehensive Review and Case Discussions. H. Luders. England.: Martin Dunitz Ltd. Publishers. 75-94.

Blume, W.T. 2000. Epilepsy with generalised tonic-clonic seizures on awakening and other idiopathic generalised epilepsies. The Epilepsies, Part II. Handbook of Clinical Neurology. 73. H. Meinardi. Amsterdam: Elsevier Science B.V. 175-182.

Blume, W.T. 2001. Focal Motor Seizures and Epilepsia Partialis Continua. The Treatment of Epilepsy: Principles & Practice. 3rd ed. E. Wyllie. Lippincott Williams & Wilkins. 329-343.

Blume, W.T., G.M. Holloway, and S. Wiebe. 2001. Temporal epileptogenesis: localizing value of scalp and subdural interictal and ictal EEG. Epilepsia 42 (4): 508-514.

Blume, W.T., M. Kaibara, and G.B. Young. 2001. Atlas of Adult Electroencephalography. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins.

Blume, W.T., D. Ociepa, and V. Kander. 2001. Frontal Lobe Seizure Propagation: EEG and Subdural EEG Studies. Epilepsia. 42 (4): 491-503.

Derry, P.A., M.C.S. Harnadek, R.S. McLachlan, J. Sontrop, W.T. Blume, and J.P. Girvin. 2001. A Longitudinal Study of the Effects of Seizure Symptoms on MMPI-2 Clinical Interpretation. Journal of Clinical Psychology

Manchanda, R., W.T. Blume, R.S. McLachlan, and S. Wiebe. 2000. Psychiatric disorders and decision for temporal lobectomy. Epilepsia 41 (Suppl. 7): 237-238.

Wiebe, S., W.T. Blume, J.P. Girvin, and M. Eliasziw. 2001. Results of a randomized controlled trial of surgical versus medical therapy of temporal. Canadian Journal of Neurological Sciences 28 (Suppl 2): S10.

Wiebe, S., W.T. Blume, J.P. Girvin, and M. Eliasziw. 2001. Results of a randomized controlled trial of surgical versus medical therapy of temporal. Neurology 52 (8) (Suppl. 3): A217.

Wieser, H.G., W.T. Blume, D. Fish, E. Goldensohn, A. Hufnagel, D. King, M.R. Sperling, and H. Luders. 2001. Commission on neurosurgery of the International League Against Epilepsy (ILAE). Epilepsia 42 (2): 282-286.

Young, G.B. 2000. EEG in the Intensive Care Unit. Atlas of Adult Electroencephalography. W.T. Blume, and M. Kaibara. New York: Raven Press.

BOLTON, C.F.

Bolton, C.F., and G.B. Young. 2000. Critical Illness Polyneuropathy. Current Treatment Options in Neurology 2 (6): 489-498.

Young, G.B., and C.F. Bolton. 2001. Renal Diseases. Diseases of the Nervous System: Clinical Neurobiology. 3rd ed. A.K. Asbury, G.M. McKhann, and W.I. McDonald. Philadelphia: W.B. Saunders.

BROWN, J.D.

Watson, B.V., M.W. Nicolle, and J.D. Brown. 2001. Conduction Block in Neuralgic Amyotrophy. Muscle & Nerve 24 (4): 559-563.

COOPER, P.E.

Cooper, P.E. 2001. Physiology and pathophysiology of the endocrine brain and hypothalamus. Principles and Practice of Endocrinology and Metabolism. 3rd ed. K.L. Becker. Philadelphia: Lippincott Williams & Wilkins. 90-97.

DUGGAL, N.

Duggal, N., V.K.H. Sonntag, and C.A. Dickman. 1990. Fusion options and indications in the lumbosacral spine. Contemporary Neurosurgery 23 (1): 1-8.

Hammond, R., N. Duggal, and J.P. Girvin. 2000. Malignant transformation of dysembryoplastic neuroepithelial tumour - a case report. Journal of Neurosurgery 92: 722-725.

FERGUSON, G.G.

Nabavi, D.G., L.M. LeBlanc, B. Baxter, D.H. Lee, A.J. Fox, S.P. Lownie, G.G. Ferguson, R.A. Craen, A.W. Gelb, and T.Y. Lee. 2001. Monitoring cerebral perfusion after subarachnoid hemorrhage. Neuroradiology 43: 7-16.

GIRVIN, J.P.

Wiebe, S., W.T. Blume, J.P. Girvin, and M. Eliasziw. 2001. Results of a randomized controlled trial of surgical versus medical therapy of temporal. Neurology 52 (8) (Suppl. 3): A217.

HACHINSKI, V.

Cheung, R.T.F., and V. Hachinski. 2000. The insula and cerebrogenic sudden death. Archives of Neurology 57: 1685-1688.

Del-Ser, T., V. Hachinski, H. Merskey, and D. Munoz. 2000. Differentiation of two subgroups of dementia with lewy bodies from Alzheimer's disease. Neurobiology of Aging 21: 1S: S147.

Demaerschalk, B.M., V. Hachinski, and S. Wiebe. 2000. Development of a formal evidence-based stroke curriculum in a neurology training program. Neurology 54 (Suppl 3): A46.

Diener, H.C., M. Cortens, G. Ford, J. Grotta, W. Hacke, M. Kaste, P.J. Koudstaal, T. Wessel, and V. Hachinski. 2000. Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 31: 2543-2551.

Hachinski, V. 2001. Vascular Dementia: It is time for a new Approach. World Neurology 16 (2): 9-11.

Hansson, L., H. Lithell, I. Skoog, F. Baro, C.M. Banki, M. Breteler, A. Castaigne, M. Correia, J.P. Degaute, D. Elmfeldt, K. Engedal, C. Farsand, J. Ferro, V. Hachinski, et al. 2000. Study on Cognition and Prognosis in the Elderly (SCOPE): baseline characteristics. Blood Pressure 9 (2-3): 146-151.

Merino, J.G., and V. Hachinski. 2001. Classification of cerebrovascular disease. Neuropsychology of cardiovascular disease. S.R. Waldstein, and M.F. Elias. Mahwah, New Jersey: Lawrence Erlbaum Associates Incorporated. 257-277.

Merino, J.G., and V. Hachinski. 2000. Leukoaraiosis. Reifying rarefaction. Archives of Neurology 57: 926-927.

Munoz, D., J. Barron, P. Martinez-Lage, C. Hyson, and V. Hachinski. 2000. Doble mutacion notch-3 Y factor v-leiden en demencia multi-infarto familiar. Neurologia 15 (455): 10.

Norris, J., V. Beletsky, Z.G. Nadareishvili, and V. Hachinski. 2000. Sudden neck movement and cervical artery dissection. Canadian Medical Association Journal 163 (1): 38-40.

O'Callaghan, C., B. Silver, B. Demaerschalk, A. Tamayo, J.G. Merion, E. Wong, S. Deshpande, E. Denomy, D. Karcz, J.D. Spence, V. Hachinski, et al. 2000. Implementation of an Acute Stroke Protocol in an Academic Hospital: Successes and Lessons Learned. Canadian Journal of Neurological Sciences Supplement (27): S25-S26.

Ostbye, T., R. Steenhuis, V. Hachinski, and The Canadian Study of Health and Aging Working Group. 2000. The incidence of dementia in Canada. Neurology 55: 66-73.

Silver, B., B. Demaerschalk, J.G. Merino, E. Wong, A. Tamayo, A. Devasenapathy, C. O'Callaghan, A. Kertesz, G.B. Young, A.J. Fox, J.D. Spence, and V. Hachinski. 2001. Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Canadian Journal of Neurological Sciences 28: 113-119.

Silver, B., B. Demaerschalk, A. Tamayo, A. Devasenapathy, J. Merino, E. Wong, J.D. Spence, G.B. Young, C. O'Callaghan, and V. Hachinski. 2000. tPA use for acute ischemic stroke in Southwestern Ontario: Safety and efficacy using CT. Canadian Journal of Neurological Sciences 27: S24.

HAHN, A.F.

Bendahhou, S., T.R. Cummins, A.F. Hahn, S. Langlois, S.G. Waxman, and L.J. Ptacek . 2000. A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation. The Journal of Clinical Investigation 106: 431-438.

Bensa, S., R.D.M. Hadden, A.F. Hahn, R.A.C. Hughes, A.V. Swan, M. Traub, and H.J. Willison. 2000. Randomised controlled trial of brain-derived neurotrophic factor in Guillain-Barre syndrome. European Journal of Neurology 7: 423-426.

Federico, P., D.W. Zochodne, A.F. Hahn, W.F. Brown, and T.E. Feasby. 2000. Multifocal motor neuropathy improved by IVIg: randomized double-blind, placebo-controlled. Neurology 55: 1256-1262.

Hadden, R.D.M., H. Karch, HP. Hartung, J. Zielasek, B. Weissbrich, J. Schubert, A. Weishaupt, D.R. Cornblath, A.V. Swan, R.A.C. Hughes, K.V. Toyka, and the Plasma Exchange Sandoglobulin Guillain-Barre Syndrome Trial Group (including A.F. Hahn). 2001. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56: 758-765.

Hahn, A.F. 2001. The challenge of respiratory dysfunction in Guillain-Barre syndrome. Archives of Neurology 58 (6): 871-872.

Hahn, A.F. 2000. Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle & Nerve. Suppl. 9: S39-48.

Hahn, A.F. 2000. Intravenous immunoglobulin treatment in peripheral nerve disorders - indications, mechanisms of action and side effects. Current Opinion in Neurology 13: 575-582.

Hahn, A.F. 2000. Neuropathies demyelinisantes acquises. La Revue Du Praticien 500: 724-730.

Hahn, A.F. 2001. Outcome measurements in the treatment of immune-mediated neuropathies. La Presse Medicale 2: 12-13.

Hahn, A.F., P.J. Ainsworth, C.F. Bolton, J.M. Bilbao, and J.M. Vallat. 2001. Pathological findings in the x-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathologica 101: 129-139.

Hahn, A.F., and G.B. Young. 2000. Festschrift for Dr. Charles Bolton, Muscle and Nerve, Special Supplement. October (Editors).

Plaster, N.M., R. Tawil, M. Tristani-Firouzi, S. Canun, S. Bendahhou, A. Soemori, M.R. Donaldson, S. Iannaccone, E. Brunt, R. Barohn, J. Clark, F. Deymeer, A.L. George, Jr, A.F. Hahn, et al. 2001. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511-519.

Scoggan, K.A., T. Chandra, R. Nelson, and A.F. Hahn. 2001. Identification of two novel mutations in the CACNA1A gene responsible for episodic ataxia. Journal of Medical Genetics 38: 249-253.

Vallat, J.M., P. Bouche, D. Cros, A.F. Hahn, J.M. Leger, L. Magy, F. Tabaraud, and P.M. Preux. 2001. Essai multicentrique (phase II) du beta-interferon-1a dans les polyradiculonevrites inflammatoires chroniques. Revue Neurologique Suppl. 1: S29.

Wilmshurst, J.M., A. Bye, C. Rittey, C. Adams, A.F. Hahn, D. Ramsay, R. Pamphlett, J.D. Pollard, and R. Ouvrier. 2001. Severe infantile axonal neuropathy with respiratory failure. Muscle & Nerve 24: 760-768.

JOG, M.

Jog, M., M. Jenkins, and C. Hyson. 2000. Movement Disorders Manual. Movement Disorders Clinic. 1st ed. London: Movement Disorder Program.

KERTESZ, A.

Baladi, J.F., P.A.B. Bailey, S. Black, R.W. Bouchard, K.D. Farcnik, S. Gauthier, A. Kertesz, E. Mohr, and A. Robillard. 2000. Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications. Clinical Therapeutics 22: 1549-1561.

Feldman, H., and A. Kertesz. 2001. Diagnosis, classification and natural history of degenerative dementias. Canadian Journal of Neurological Sciences 28 (Suppl 1): S17-S27.

Gold, B.T., and A. Kertesz. 2001. Phonologically related lexical repetition disorder: A case study. Brain and Language 77: 241-265.

Gold, B.T., and A. Kertesz. 2000. Preserved visual lexicosemantics in global aphasia: A right-hemisphere contribution? Brain and Language 75: 359-375.

Gold, B.T., and A. Kertesz. 2000. Right hemisphere semantic processing of visual words in an aphasic patient: An fMRI study. Brain and Language 73: 446-465.

Kertesz, A. 2001. Aphasia and Stroke. Stroke Symptoms. 2nd ed. J. Bogousslavsky, and L. Caplan. Cambridge: Cambridge University Press. 211-221.

Kertesz, A. 2000. Behavioral and psychological symptoms and frontotemporal dementia (Pick's disease). International Psychogeriatrics 12 (Suppl 1): 183-187.

Kertesz, A. 2001. Manifestations of aphasic symptoms in Hungarian. Manifestations of aphasia symptoms in different languages. M. Paradis. Oxford, UK: Pergamon. 229-235.

Kertesz, A. 2001. Pick complex: Cutting through the confusion about Pick's disease and frontotemporal. The Canadian Alzheimer Disease Review 4: 5-8.

Kertesz, A., P. Martinez-Lage, W. Davidson, and D.G. Munoz. 2000. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal. Neurology 55: 1368-1375.

Kertesz, A., and J. Osman-Sagi. 2001. Manifestations of aphasic symptoms in Hungarian. IALP proceedings. Journal of Neuroloinguistics. 14: 313-319.

LOWNIE, S.P.

MCLACHLAN, R.S.

Bayliff, C., J. Bruni, P. Camfield, S. Cowen, A. Guberman, M. Jones, S. Lovell, R.S. McLachlan, M. Sundaram, and G.B. Young. 2001. Anti-epileptic Drug Therapy. CPS 2001. C. Gillis. Ottawa: Canadian Pharaceutical Society. L55-L58.

Manchanda, R., W.T. Blume, R.S. McLachlan, and S. Wiebe. 2000. Psychiatric disorders and decision for temporal lobectomy. Epilepsia 41 (Suppl. 7): 237-238.

NICOLLE, M.W.

Nicolle, M.W., J.R. Barron, B.V. Watson, R. Hammond, and T.A. Miller. 2001. Wartenberg's migrant sensory neuritis. Muscle & Nerve 24 (3): 438-443.

Ostermann, M.E., G.B. Young, W.J. Sibbald, and M.W. Nicolle. 2000. Coma mimicking brain death following baclofen overdose. Intensive Care Medicine 26 (8): 1144-1146.

Watson, B.V., M.W. Nicolle, and J.D. Brown. 2001. Conduction Block in Neuralgic Amyotrophy. Muscle & Nerve 24 (4): 559-563.

PARRENT, A.G.

Finnis, K.W., Y.P. Starreveld, A.G. Parrent, and T.M. Peters. 2000. A 3-Dimensional Database of Deep Brain Functional Anatomy, and Its Application to Image-Guided Neurosurgery. Medical Image Computer and Computer - Assisted Intervention - MICCAI 2000. 3rd International Conference. Pittsburgh, PA: Delp, DiGioia, and Jaramaz. Springer. 1-8.

Parrent, A.G. 2001. Stereotactic radiofrequency ablation for the treatment of gelastic seizures associated with hypothalamic hamartoma. Search on Epilepsy, Excerpta Medica Medical Communications 8 (1): 12-14.

Parrent, A.G., and A.M. Lozano. 2000. Stereotactic surgery for temporal lobe epilepsy. Canadian Journal of Neurological Sciences 27 (Suppl. 1): S79-S84.

Wiebe, S., W.T. Blume, J.P. Girvin, M. Eliasziw, and EESTLE Study Group. 2001. A randomized, controlled trial of surgery for temporal lobe epilepsy. New England Journal of Medicine 345: 311-318.

RICE, G.P.A.

Comi, G., M. Filippi, G.P.A. Rice, and European/Canadian Glatiramer Acetate Study Group. 2001. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. Annals of Neurology 49 (3): 297-297.

Ebers, G.C., I.M. Yee, A.D. Sadovnick, G.P.A. Rice, P. Duquette, and The Canadian Collaborative Study Group. 2000. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in. Annals of Neurology 48 (6): 927-931.

Hughes, R., and The PRISMS Study group (including G.P.A. Rice). 2001. PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology 56 (12): 1628-1636.

Jacobs, L.D., W.B. Roy, J.H. Simon, R.P. Kinkel, C.M. Brownscheidle, T.J. Murray, N.A. Simonian, P.J. Slasor, A.W. Sandrock, and The CHAMPS study group (including Rice, G.P.A.). 2000. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. New England Journal of Medicine 343 (13): 898-904.

Li, D.K.B., G.J. Zhao, D.W. Paty, and UBC MS/MRI Analysis Research Group and the SPECTRIMS Study Group (including G.P.A. Rice). 2001. Randomized controlled trial of interferon-beta-1a in secondary progressive MS MRI. Neurology 56 (June): 1505-1513.

Mandalfino, P., G.P.A. Rice, A. Smith, J.L. Klein, L. Rystedt, and G.C. Ebers. 2000. Bone marrow transplantation in multiple sclerosis. Journal of Neurology 247 (8): 691-695.

Rice, G.P.A. (Editor). 2000. Compass, Navigating Life With MS. Vol. Winter Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2000. Compass, Navigating Life With MS. Vol. Autumn Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2001. Compass, Navigating Life With MS. Vol. Spring Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2001. Medical Forum on MS. Neuro/Transmission. Vol. 2 (1 (Spring)). Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2000. Neuro/Transmission, Medical Forum on MS. Vol. 1 (Winter). Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2000. Neuro/Transmission, Medical Forum on MS. Vol. 1 (Autumn). Montreal: Parkhurst Publishing.

Rice, G.P.A. (Editor). 2001. Neuro/Transmission, Medical Forum on MS. Vol. 2 (Spring). Montreal: Parkhurst Publishing.

Rice, G.P.A. 2001. Treatment of Multiple Sclerosis: Bone Marrow Reconstitution, Total Lymphoid Irradiation, and Plasma Exchange. Handbook of Multiple Sclerosis. 3rd ed. S.D. Cook. New York, NY: Marcel Dekker Inc.

Rice, G.P.A., and G.C. Ebers. 2000. Multiple Sclerosis: Current Treatment. Melmon and Morrelli's Clinical Pharmacology: The Principles and Practical Application of Therapeutics. 4th ed. McGraw-Hill Publishers. 453-460.

Sadovnick, A.D., I.M. Yee, G.C. Ebers, and Canadian Collaborative Study Group (including G.P.A. Rice). 2001. Recurrence risks to sibs of MS index cases: Impact of consanguineous matings. Neurology 56 (April ): 784-785.

Sadovnick, A.D., I.M.L. Yee, G.P.A. Rice, G.C. Ebers, and The Canadian Collaborative Study Group. 2000. Factors Influencing Sib Risks for MS. Clinical Genetics 58: 431-435.

SPECTRIMS Study Group (including G.P.A. Rice). 2001. Randomized controlled trial of interferon-beta 1a in secondary progressive MS: clinical. Neurology 56 (June): 1496-1504.

SAHJPAUL, R.L.

Sahjpaul, R.L. 2001. Awake craniotomy: controversies, indications and techniques in the surgical treatment of temporal lobe epilepsy. Canadian Journal of Neurological Sciences 27 (1): S55-S63.

Sahjpaul, R.L., and M. Girotti. 2001. Intracranial Pressure Monitoring in Severe Traumatic Brain Injury - Results of a Canadian. Canadian Journal of Neurological Sciences 27: 143-147.

SPENCE, J.D.

Hackam, D.G., L.M.F. Thain, A. Abassakoor, F.N. McKenzie, and J.D. Spence. 2001. Trapped renal arteries: Functional renal artery stenosis due to occlusion of the aorta in the arch and below the kidneys. Canadian Journal of Cardiology 17: 587-592.

Merino, J.G., M. Eliasziw, J.D. Spence, and H.J.M. Barnett. 2001. Serum creatinine concentration and the risk of stroke, myocardial infarction, and vascular death in patients with symptomatic carotid stenosis. Stroke 32: 365.

Merino, J.G., B. Silver, A. Tamayo, E. Wong, B. Demaerschalk, A. Devasenapathy, C. O'Callaghan, A. Kertesz, G.B. Young, J.D. Spence, and V. Hachinski. 2001. Tissue plasminogen activator for rural referrals; the effect of stroke team notification prior to arrival. Stroke 32 (1): P375.

O'Callaghan, C., B. Silver, B. Demaerschalk, A. Tamayo, J.G. Merion, E. Wong, S. Deshpande, E. Denomy, D. Karcz, J.D. Spence, V. Hachinski, and others. 2000. Implementation of an Acute Stroke Protocol in an Academic Hospital: Successes and Lessons Learned. Canadian Journal of Neurological Sciences Supplement (27): S25-S26.

Spence, J.D. 2001. First-line drugs for hypertension. Canadian Medical Association Journal 164: 176-177.

Spence, J.D. 2001. New approaches to atherosclerosis based on endothelial function. Current Review of Cerebrovascular Disease. 4th ed. M. Fisher, and J. Bogousslavsky. Philadelphia: Current Medicine. 1-14.

Spence, J.D. 2001. Patients with atherosclerotic vascular disease: How low should plasma homocyst(e)ine. American Journal of Cardiovascular Drugs 1: 85-89.

Spence, J.D. 2001. Vitamins and antioxidants. Drug Therapy for Stroke Prevention. J. Bogousslavy. London, England: Taylor and Francs. 231-246.

Spence, J.D., and M. Eliasziw. 2001. Endarterectomy or angioplasty for treatment of carotid stenosis? Lancet 357: 1722-1723.

Spence, J.D., V.J. Howard, L.E. Chambless, M.R. Malinow, L.C. Pettigrew, M. Stampfer, and J.F. Toole. 2001. Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and design. Neuroepidemiology 20 (1): 16-25.

Spence, J.D., and J.F. Toole. 2001. Homocysteine and Cerebral Vascular Disease. Homocysteine in Health and Disease. R. Carmel. New York: Hermitage Publishing Services. 384-392.

STRONG, M.J.

He, B., and M.J. Strong. 2000. A morphological analysis of the motor neuron degeneration and microglial reaction in acute and chronic in vivo aluminum chloride neurotoxicity. Journal of Chemical Neuroanatomy 17: 207-215.

Strong, M.J. 2001. Aluminum as an experimental neurotoxicant. Aluminum and Alzheimer's Disease. C. Exley. London: Elsevier Press.

Strong, M.J., W.L. Strong, B. Traggert, H. Jaffe, M.M. Sopper, and H.C. Pant. 2001. Phosphorylation state of the native high molecular weight neurofilament subunit protein (NFH) from cervical spinal cord in sporadic amyotrophic lateral sclerosis (ALS). Journal of Neurochemistry 76: 1-12.

Wong, N., B. He, and M.J. Strong. 2000. Altered stoichiometry of intermediate filament protein expression in cervical spinal cord in amyotrophic lateral sclerosis (ALS). Neurology 54: 154.

Wong, N.K.Y., B.P. He, and M.J. Strong. 2000. Characterization of Neuronal Intermediate Filament Protein Expression in Cervical Spinal Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis (ALS). Journal of Neuropathology and Experimental Neurology 59: 972-982.

WATLING, C.J.

Watling, C.J., and D.E. Moulin. 2001. Neuropathic Pain. Cancer Pain. R.K. Portenoy, and E. Bruera. New York: Cambridge University Press.

WIEBE, S.

Blume, W.T., G.M. Holloway, and S. Wiebe. 2001. Temporal epileptogenesis: localizing value of scalp and subdural interictal and ictal EEG. Epilepsia 42 (4): 508-514.

Demaerschalk, B.M., V. Hachinski, and S. Wiebe. 2000. Development of a formal evidence-based stroke curriculum in a neurology training program. Neurology 54 (Suppl 3): A46.

Gawel, M., and S. Wiebe. 2000. Evidence-based analysis of a migraine treatment drug comparison trial. Cephalalgia 20: 33-38.

Manchanda, R., W.T. Blume, R.S. McLachlan, and S. Wiebe. 2000. Psychiatric disorders and decision for temporal lobectomy. Epilepsia 41 (Suppl. 7): 237-238.

Wiebe, S. 2001. The principles of evidence-based medicine. Cephalalgia 20 (Suppl. 2): 10-13.

Wiebe, S., W.T. Blume, J.P. Girvin, and M. Eliasziw. 2001. Results of a randomized controlled trial of surgical versus medical therapy of temporal. Neurology 52 (8) (Suppl. 3): A217.

Wiebe, S., M. Eliasziw, and S. Matijevic. 2001. Changes in Quality of Life in Epilepsy: How Large Must They Be to Be Real? Epilepsia 42 (1): 113-118.

Wiebe, S., and S.M. Matijevic. 2000. How much improvement in quality of life must patients have for epilepsy therapies to be. Epilepsia 41 (Suppl. 7): 142.

YOUNG, G.B.

Bolton, C.F., and G.B. Young. 2000. Critical Illness Polyneuropathy. Current Treatment Options in Neurology 2 (6): 489-498.

Cooper, A.B., K.S. Thornley, G.B. Young, A.S. Slutsky, T.E. Stewart, and P.J. Hanly. 2000. Sleep in critically ill patients requiring mechanical ventilation. Chest 117 (3): 809-819.

De Rubeis, D.A., and G.B. Young. 2001. Continuous EEG monitoring in a patient with massive carbamazepine overdose. J Clin Neurophysiol 18 (2): 166-168.

Hahn, A.F., and G.B. Young. 2000. Festschrift for Dr. Charles Bolton, Muscle and Nerve, Special Supplement. October (Editors).

Ostermann, M.E., G.B. Young, W.J. Sibbald, and M.W. Nicolle. 2000. Coma mimicking brain death following baclofen overdose. Intensive Care Medicine 26 (8): 1144-1146.

Young, G.B. 2001. Aspects of Metabolic Coma. Neurologic Therapeutics: Principles and Practice. J.H. Noseworthy. London: Martin Dunitz Publisher.

Young, G.B. 2000. Disorders of Consciousness. Encyclopedia of Neuroscience. M. Aminoff, and R.B. Daroff. San Diego: Academic Press. (Section Editor).

Young, G.B. 2000. The EEG in coma. Journal of Clinical Neurophysiology 17 (5): 453-456.

Young, G.B. 2000. EEG in the Intensive Care Unit. Atlas of Adult Electroencephalography. W.T. Blume, and M. Kaibara. New York: Raven Press.

Young, G.B. 2000. Encephalopathy, Coma and Brain Death. Saunder's Manual of Neurologic Practice. R.W. Evans. Philadelphia: Saunder's.

Young, G.B. 2000. Ethics in the ICU with Emphasis on Comatose Survivors of Cardiac Arrest. Journal of Clinical Neurophysiology 17: 456-456.

Young, G.B., and C.F. Bolton. 2001. Renal Diseases. Diseases of the Nervous System: Clinical Neurobiology. 3rd ed. A.K. Asbury, G.M. McKhann, and W.I. McDonald. Philadelphia: W.B. Saunders.

Young, G.B., and O.P. da Silva. 2000. Effects of morphine on the electroencephalograms of neonates: a prospective, observational. Clinical Neurophysiology 111 (11): 1955-1960.

Young, G.B., S.H. Eldien, and O.P. daSilva. 2000. The Effect of Morphine on the Neonatal EEG. Journal of Clinical Neurophysiology 17: 532.